Sumsuzzman D M, Wang Z, Langley JM, Moghadas SM, Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: A systematic review and meta-analysis, The Lancet Child & Adolescent Health 2025, 9: 393-403.
Du Z, Pandey A, Moghadas SM, Bai Y, Wang L, Matrajt L, Singer BH, Galvani AP, Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults, Nature Medicine 2025, 31(2): 647-652.
Moghadas SM, Shoukat A, Bawden CE, Langley JM, Singer BH, Fitzpatrick MC, Galvani AP. Cost-effectiveness of prefusion F protein-based vaccines against respiratory syncytial virus disease for older adults in the United States. Clinical Infectious Diseases. 2024, 78(5): 1328-1335.
Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM, Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: A simulation study, The Lancet Regional Health - Americas 2023, 28: 100629.
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP, The implications of silent transmission for the control of COVID-19 outbreaks, Proceedings of the National Academy of Sciences USA 2020, 117(30): 17513–17515.
For citation of our published studies, visit Google Scholar
Moghadas SM, Sah P, Shoukat A, Meyers LA, Galvani AP, Population immunity against COVID-19 in the United States, Annals of Internal Medicine 2021, 174(11):1586-1591.
Sah P, Vilches TN, Shoukat A, PandeyA, FitzpatrickMC, Moghadas SM, Galvani AP, Quantifying the potential dominance of immune-evading SARS-CoV-2 variants in the United States, medRxiv 2021, DOI: 10.1101/2021.05.10.21256996.
Sah P, Moghadas SM, Vilches TN, ShoukatA, SingerBH, HotezPJ, SchneiderEC, Galvani AP, Implications of suboptimal COVID-19 vaccination coverage in Florida and Texas, The Lancet Infectious Diseases 2021, 21(11): 1493-1494.
Sah P, Fitzpatrick MC, Zimmer CF, Abdollahi E, Juden-Kelly L, Moghadas SM, Singer BH, Galvani AP, Asymptomatic COVID-19 infection: a systematic review and meta-analysis, Proceedings of the National Academy of Sciences USA 2021, 118; 34: e2109229118.
Nourbakhsh S, Shoukat A, Zhang K, Poliquin G, Halperin D, Sheffield H, Halperin SA, Langley JM, Moghadas SM, Effectiveness and cost-effectiveness of RSV infant and maternal immunization programs: a case study of Nunavik, Canada, eClinicalMedicine 2021, 41: 101141.
Vilches TN, Sah P, Abdollahi E, Moghadas SM, Galvani AP, Importance of non-pharmaceutical interventions in the COVID-19 vaccination era: a case study of the Seychelles, Journal of Global Health 2021, 11: 03104.
Moghadas SM, Sah P, Vilches TN, Galvani AP, Can the USA return to pre-COVID-19 normal by July 4th? The Lancet Infectious Diseases 2021, S1473-3099(21)00324-8.
Pandey A, Sah P, Moghadas SM, Mandal S, Banerjee S, Hotez PJ, Galvani AP, Challenges facing COVID-19 vaccination in India: lessons from the initial vaccine rollout, Journal of Global Health 2021, 11: 03083.
Sah P, Vilches TN, Moghadas SM, Fitzpatrick MC, Singer BH, Hotez PJ, Galvani AP, Accelerated vaccine rollout is imperative to mitigate highly transmissible COVID-19 variants, eClinicalMedicine 2021, 35: 100865.
Vilches TN, Zhang K, Van Exan R, Langley JM, Moghadas SM, Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada, Vaccine 2021, 39: 2360–2365.